GET Analyst Insights

Get the qualitative summaries of Analyst Research Reports

Response (200 OK)

{
"action": "Reiterates",
"analyst_insights": "This morning, HC Wainwright & Co. reiterated their Buy rating on Cybin's stock with a price target of $5.0000. - **Advancing Clinical Pipeline:** Cybin is making significant strides in its clinical development programs, with a focus on progressing CYB003 for major depressive disorder (MDD) and CYB004 for generalized anxiety disorder (GAD) into the next phases of clinical trials. The company plans to report three-month efficacy data from a Phase 2 trial of CYB003 and is preparing for an end-of-Phase 2 meeting with the FDA, demonstrating a clear path forward for these programs.\n\n- **Positive Valuation Model:** HC Wainwright & Co. employs a discounted cash flow (DCF)-based valuation methodology, assigning a 55% probability of success for CYB003 in treating MDD and a 45% probability for CYB004 in treating GAD. These probabilities, along with planned equity raises and a conservative discount rate, support a $5 price target, suggesting confidence in Cybin’s potential market value and future revenue generation capabilities from these treatments.\n\n- **Strategic Regulatory Milestones:** Cybin has received FDA clearance to initiate a Phase 2a trial evaluating CYB004 in GAD, expected to start in 1Q24. This clearance, coupled with the planned end-of-Phase 2 meeting for CYB003, indicates regulatory progress and positions Cybin favorably for advancing its therapeutic candidates through the clinical development process, ultimately enhancing shareholder value.",
"date": "2024-02-15",
"firm": "HC Wainwright & Co.",
"firm_id": "5c383d9b0448fc02d76b09d5",
"id": "65ce4cb3ba47d164700176bf",
"pt": "5.0000",
"rating": "Buy",
"rating_id": "65ce4c5d0ebf29000101f29b",
"security": {
"cik": "",
"exchange": "AMEX",
"isin": "",
"name": "Cybin",
"symbol": "CYBN"
},
"updated": 1708018876
}

Authorizations

token

string

query

required

Query Parameters

page

integer

default:1

Page number for pagination.

pageSize

integer

default:10

Number of items per page.

symbols

string

Stock ticker symbols separated by commas to query for analyst insights.

analyst

string

One or more analyst ids separated by a comma.

rating_id

string

One or more rating ids separated by a comma.

search_keys_type

enum<string>

If you wanna query by firm Id or firm name, use this parameter and pass the key. Currently supported are [firm_id, firm]

Available options:

firm_id,

firm

search_keys

string

If you have selected search_keys_type, pass the appropriate identifier here.

Response

200

application/json

An array of analyst insights for the requested ticker symbol.

action

string

Analyst's action on the stock (e.g., Maintains, Upgrades).

analyst_insights

string

Detailed insights from the analyst.

date

string

Date of the analyst insight.

firm

string

Name of the firm providing the insight.

firm_id

string

Unique identifier for the firm.

id

string

Unique identifier for the analyst insight.

pt

string

Price target given by the analyst.

rating

string

Rating provided by the analyst.

rating_id

string

Unique identifier for the rating.

security

object

Security details for which the insight is provided.

Show child attributes

security.cik

string

security.exchange

string

security.isin

string

security.name

string

security.symbol

string

updated

integer

Timestamp of when the insight was last updated.